StockData
Bruker Corp logo

Bruker Corp (BRKR) stock

BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30307% above fair value
$63.26+1.90 (+3.10%)

Close on Nov 18, 2026Market cap $9.81BP/E –Yield –

Bruker gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Bruker's gross profit for the twelve months ending Jun 30, 2026 was $1.62B, down 2.2% year over year. For fiscal 2025 it was $1.58B, down 4.4% from the year before. Over ten years it grew 8.3% a year on average. The highest annual figure on record is $1.65B in fiscal 2024.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.58B-4.4%
FY2024Dec 31, 2024$1.65B+9.0%
FY2023Dec 31, 2023$1.51B+15.9%
FY2022Dec 31, 2022$1.31B+7.9%
FY2021Dec 31, 2021$1.21B+28.7%
FY2020Dec 31, 2020$939.80M-5.6%
FY2019Dec 31, 2019$995.30M+10.6%
FY2018Dec 31, 2018$900.00M+10.3%
FY2017Dec 31, 2017$816.00M+9.5%
FY2016Dec 31, 2016$745.30M+5.2%
FY2015Dec 31, 2015$708.60M-7.2%
FY2014Dec 31, 2014$763.30M-5.2%
FY2013Dec 31, 2013$805.20M-2.9%
FY2012Dec 31, 2012$829.40M+10.2%
FY2011Dec 31, 2011$752.50M+24.6%
FY2010Dec 31, 2010$604.00M+16.7%
FY2009Dec 31, 2009$517.50M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$416.00M+16.2%
Q1 FY2026Mar 31, 2026$379.80M-2.9%
Q4 FY2025Dec 31, 2025$449.20M-8.9%
Q3 FY2025Sep 30, 2025$379.40M-9.4%
Q2 FY2025Jun 30, 2025$357.90M-6.9%
Q1 FY2025Mar 31, 2025$391.20M+10.9%
Q4 FY2024Dec 31, 2024$493.30M+14.6%
Q3 FY2024Sep 30, 2024$418.80M+9.4%
Q2 FY2024Jun 30, 2024$384.60M+13.0%
Q1 FY2024Mar 31, 2024$352.80M-1.9%
Q4 FY2023Dec 31, 2023$430.30M+17.6%
Q3 FY2023Sep 30, 2023$382.80M+14.2%
Q2 FY2023Jun 30, 2023$340.50M+14.2%
Q1 FY2023Mar 31, 2023$359.70M+17.4%
Q4 FY2022Dec 31, 2022$365.90M+7.1%
Q3 FY2022Sep 30, 2022$335.30M+8.6%
Q2 FY2022Jun 30, 2022$298.20M+6.3%
Q1 FY2022Mar 31, 2022$306.30M+9.9%
Q4 FY2021Dec 31, 2021$341.60M+9.1%
Q3 FY2021Sep 30, 2021$308.70M+24.3%
Q2 FY2021Jun 30, 2021$280.60M+50.7%
Q1 FY2021Mar 31, 2021$278.70M+44.9%
Q4 FY2020Dec 31, 2020$313.00M+5.6%
Q3 FY2020Sep 30, 2020$248.30M-2.2%
Q2 FY2020Jun 30, 2020$186.20M-19.2%
Q1 FY2020Mar 31, 2020$192.30M-10.4%
Q4 FY2019Dec 31, 2019$296.30M+8.6%
Q3 FY2019Sep 30, 2019$253.90M+14.1%
Q2 FY2019Jun 30, 2019$230.40M+12.3%
Q1 FY2019Mar 31, 2019$214.70M+7.7%
Q4 FY2018Dec 31, 2018$272.80M+6.5%
Q3 FY2018Sep 30, 2018$222.60M+11.9%
Q2 FY2018Jun 30, 2018$205.20M+11.2%
Q1 FY2018Mar 31, 2018$199.40M+13.0%
Q4 FY2017Dec 31, 2017$256.20M+16.2%
Q3 FY2017Sep 30, 2017$198.90M+7.4%
Q2 FY2017Jun 30, 2017$184.50M–
Q1 FY2017Mar 31, 2017$176.40M–
Q4 FY2016Dec 31, 2016$220.40M–
Q3 FY2016Sep 30, 2016$185.20M–

More Bruker figures

See a number that looks wrong?